JANX
Janux Therapeutics Inc Earnings
$31.83
Earnings Summary
Revenue | $0Mn |
Net Profits | $-20.22Mn |
Net Profit Margins | -Inf% |
Janux Therapeutics Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2024. On a quarterly growth basis, Janux Therapeutics Inc has generated -100% fall in its revenue since last 3-months.
Janux Therapeutics Inc’s net profit fell -71.93% since last year same period to $-20.22Mn in the Q4 2024. On a quarterly growth basis, Janux Therapeutics Inc has generated 27.95% jump in its net profits since last 3-months.
Janux Therapeutics Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2024. On a quarterly growth basis, Janux Therapeutics Inc has generated -Inf% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.45 |
EPS Estimate Current Year | -0.45 |
Janux Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.45 - a -27.08% fall from last quarter’s estimates.
Janux Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.45.
Key Ratios
Earning Per Share (EPS) | -0.36 |
Janux Therapeutics Inc’s earning per share (EPS) fell -44% since last year same period to -0.36 in the Q4 2024. This indicates that the Janux Therapeutics Inc has generated -44% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-07 | -0.31 | -0.11 | 64.52% |
2024-05-08 | -0.33 | -0.3 | 9.09% |
2024-11-06 | -0.36 | -0.51 | -42.98% |
